HX009
Based on 1 Customer Validation
HX009 is a bispecific antibody targeting PD1 and CD47, but with weakened CD47 binding. HX009 blocks the functional of PD1/CD47. HX009 can be used for the study of non-Hodgkin’s lymphoma (NHL).
For research use only. We do not sell to patients.
- Purity: 99.56%
- Molecular Weight:173.16 kDa
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Human IgG4 kappa
Human
CD47 & PD-1
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Q61735-1 & Q02242
Unconjugated
The product can be reconstituted/diluted with sterile PBS or saline.
-
extracellular CD47-binding domain of human SIRPα protein at the C-terminus (Fc) of the heavy chain of HX008
ELISA, FACS, Functional assay
-
Immobilized human PD-1-His can bind HX009. The EC50 for this effect is 55.64 ng/mL. -
Immobilized human-CD47-His can bind HX009. The EC50 for this effect is 172.1 ng/mL.
Chemical Information
-
Appearance Liquid
-
Molecular Weight 173.16 kDa
-
Color Colorless to light yellow
-
SMILES
N/A
-
Shipping
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
-
Data Sheet (255 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)